No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
226 |
4. Check minimum number of eventsNone |
226 |
5. Include endpointsNone |
226 |
6. Filter based on genotype QC (FinnGen only) |
226 |
Control definitions (FinnGen only)
- Control exclude
- M13_ARTHROPATHIES
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Deformity of finger(s)
based on the number of shared cases.
Similar with more cases:
- Other joint disorders
- Arthropathies
- Diseases of the musculoskeletal system and connective tissue
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 1492 | 854 | 627 |
| Only index persons | 1395 | 803 | 592 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.02 | 0.02 | 0.02 |
| Only index persons | 0.03 | 0.03 | 0.02 |
| Median age at first event (years) | |||
| Whole population | 50.52 | 50.87 | 49.88 |
| Only index persons | 50.09 | 50.51 | 49.51 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 226 | 133 | 93 |
| Unadjusted period prevalence (%) | 0.04 | 0.05 | 0.04 |
| Median age at first event (years) | 52.14 | 50.39 | 54.63 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 207
- Matched controls
- 2068
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
M20.00
ICD-10 Finland
Buttonhole deformity of fingers
+∞
126.3
108
*
M20.01
ICD-10 Finland
Swan neck deformity of fingers
+∞
51.2
47
*
M20.08
ICD-10 Finland
Deformity of finger(s)
+∞
50.0
46
*
M20.1
ICD-10 Finland
Hallux valgus (acquired)
51.7
38.1
45
11
M19.0
ICD-10 Finland
Primary arthrosis of other joints
52.2
29.8
35
8
M17.1
ICD-10 Finland
Other primary gonarthrosis
21.1
23.1
34
19
NDU20
NOMESCO Finland
Removal of internal fixation device from wrist or hand
40.1
22.7
28
8
NHK30
NOMESCO Finland
Osteotomy or rotation osteotomy of first metatarsal or tarsal bone
+∞
22.3
21
*
NHG80
NOMESCO Finland
Fusion of first tarsometatarsal joint
+∞
21.2
20
*
M20.4
ICD-10 Finland
Other hammer toe(s) (acquired)
64.2
20.3
23
*
A07EC01
ATC
sulfasalazine; oral, rectal
20.0
18.8
28
16
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
+∞
18.0
17
*
M16.1
ICD-10 Finland
Other primary coxarthrosis
104.0
17.9
19
*
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
11.7
17.7
33
33
NHG70
NOMESCO Finland
Arthroplasty of first tarsometatarsal joint
+∞
16.9
16
*
NGB20
NOMESCO Finland
Primary total prosthetic replacement of knee joint without patellar part
+∞
15.8
15
*
M23.2
ICD-10 Finland
Derangement of meniscus due to old tear or injury
+∞
15.8
15
*
M25.5
ICD-10 Finland
Pain in joint
4.4
15.4
64
192
M20.2
ICD-10 Finland
Hallux rigidus
+∞
14.8
14
*
NHK40
NOMESCO Finland
Osteotomy or rotation osteotomy of II-V metatarsal or tarsal bone
+∞
14.8
14
*
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
7.5
14.1
34
53
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
11.6
13.1
24
23
M17.0
ICD-10 Finland
Primary gonarthrosis, bilateral
13.5
12.9
22
18
NDG76
NOMESCO Finland
Fusion of DIP joint
74.5
12.7
14
*
S66.3
ICD-10 Finland
Injury of extensor muscle and tendon of other finger at wrist and hand level
14.4
12.7
21
16
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
9.4
12.7
26
31
NDL99
NOMESCO Finland
Other operation on muscle or tendon of wrist or hand
+∞
12.6
12
*
NHG77
NOMESCO Finland
Arthroplasty of interphalangeal tarsal joint(s)
+∞
12.6
12
*
P01BA02
ATC
hydroxychloroquine; oral
11.6
12.6
23
22
NJ2MA
NOMESCO Finland
Measurement of mechanical axis of lower leg with X-ray
137.9
12.6
13
*
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
11.0
11.8
22
22
NGF25
NOMESCO Finland
Operation for osteochondritis of knee, arthroscopic
24.6
11.8
16
7
NFB30
NOMESCO Finland
Primary total prosthetic replacement of hip joint not using cement
+∞
10.5
10
*
L04AA13
ATC
leflunomide; oral
+∞
10.5
10
*
73799
ICD-8 Finland
Hallux valgus and varus
+∞
10.5
10
*
R4120
NOMESCO Finland
Occupational therapy
6.2
10.4
28
51
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
27.5
9.9
13
5
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
5.9
9.8
27
51
L88
ICPC
Rheumatoid/seropositive arthritis
23.0
9.5
13
6
M06.9
ICD-10 Finland
Rheumatoid arthritis, unspecified
+∞
9.4
9
*
M05.9
ICD-10 Finland
Seropositive rheumatoid arthritis, unspecified
+∞
9.4
9
*
M79.6
ICD-10 Finland
Pain in limb
2.7
9.2
79
384
M16.0
ICD-10 Finland
Primary coxarthrosis, bilateral
38.5
9.1
11
*
N03AX12
ATC
gabapentin; oral
3.7
9.0
41
130
M19.1
ICD-10 Finland
Post-traumatic arthrosis of other joints
52.2
8.7
10
*
NDL32
NOMESCO Finland
Suture or reinsertion of tendon of wrist or hand, extensor tendon
28.8
8.6
11
*
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
13.5
8.5
14
11
7362A
ICD-9 Finland
Other acquired deformities of limbs, Other acquired deformities of finger[DEFORMATIO BOUTONNIôRE]
+∞
8.4
8
*
T92.5
ICD-10 Finland
Sequelae of injury of muscle and tendon of upper limb
+∞
8.4
8
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.4
8.3
96
543
X58
ICD-10 Finland
Exposure to other specified factors
3.7
8.3
37
115
M01AH05
ATC
etoricoxib; oral
2.3
8.0
116
730
N03AX16
ATC
pregabalin; oral
2.9
8.0
54
226
N02AX02
ATC
tramadol; systemic, rectal
2.4
7.9
89
494
H02AB06
ATC
prednisolone; systemic
2.3
7.8
98
573
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
46.7
7.8
9
*
NDM99
NOMESCO Finland
Other operation on fascia, ganglion, synovial sheath or bursa of wrist or hand
46.7
7.8
9
*
S18
ICPC
Laceration/cut
2.3
7.6
89
503
NF1AA
NOMESCO Finland
Hip X-ray examination
8.2
7.5
16
21
ZXA00
NOMESCO Finland
Right side
2.7
7.5
59
268
NHG76
NOMESCO Finland
Arthroplasty of other tarsometatarsal joint
82.9
7.5
8
*
281
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
82.9
7.5
8
*
WX320
NOMESCO Finland
Spinalanesthesy
3.2
7.4
41
149
ZXA05
NOMESCO Finland
Left side
2.7
7.4
56
247
M01AX05
ATC
glucosamine; oral
3.4
7.4
36
120
L04AX01
ATC
azathioprine; systemic
7.8
7.3
16
22
M19.2
ICD-10 Finland
Other secondary arthrosis
+∞
7.3
7
*
T92.3
ICD-10 Finland
Sequelae of dislocation, sprain and strain of upper limb
31.2
7.2
9
*
NH3EA
NOMESCO Finland
Feet X-ray examination with load
31.2
7.2
9
*
SPAT1149
SPAT
Suture or treatment of traumatic wound
3.3
7.2
37
129
M75.1
ICD-10 Finland
Rotator cuff syndrome
2.7
7.1
52
226
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
2.2
6.7
94
568
NGA30
NOMESCO Finland
Exploration of knee joint, arthroscopic
12.8
6.7
11
9
L12
ICPC
Hand/finger symptom/complaint
3.1
6.6
37
137
M24.4
ICD-10 Finland
Recurrent dislocation and subluxation of joint
71.9
6.5
7
*
NH3BA
NOMESCO Finland
Foot and toes extensive X-ray examination
14.9
6.5
10
7
N06AA09
ATC
amitriptyline; systemic
3.9
6.4
25
70
NDL62
NOMESCO Finland
Shortening of tendon of hand
+∞
6.3
6
*
NDL54
NOMESCO Finland
Tenolysis of hand
+∞
6.3
6
*
NF1DA
NOMESCO Finland
X-ray of hips
27.6
6.3
8
*
TQW40
NOMESCO Finland
Remowal of suture of skin
4.3
6.2
22
56
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.3
6.2
66
350
TNX33
NOMESCO Finland
Custom moulded cast, unspecified region
5.1
6.1
18
38
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
2.3
6.1
60
307
M01AX17
ATC
nimesulide; oral
2.5
6.0
51
239
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
11
12
9.58
9.05
1.8
1.1
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
128
856
2.14
7.24
8.5
4.7
e9/l
0.0
0.0
0.48
119
723
(3013115) Eosinophils [#/volume] in Blood
131
890
2.12
7.04
8.5
5.1
e9/l
0.2
0.2
0.01
123
767
(3001604) Monocytes [#/volume] in Blood
127
856
2.10
6.93
8.4
4.7
e9/l
0.6
0.6
0.77
119
719
(3019198) Lymphocytes [#/volume] in Blood
129
880
2.09
6.76
8.4
4.7
e9/l
1.8
2.0
0.69
120
763
(42870588) Differential panel, method unspecified - Blood
91
549
2.10
6.60
8.1
4.8
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
71
392
2.18
6.45
2.3
2.4
umol/l
330.4
11847.4
3.16
63
348
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
45
215
2.36
5.71
1.4
1.1
u/ml
30.1
1.5
0.59
14
84
(3042936) Bacteria identified in Isolate by Culture
46
222
2.35
5.70
1.8
2.0
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
163
1259
2.06
5.55
7.1
3.2
mm/h
13.0
11.1
0.77
154
1141
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
47
233
2.28
5.47
1.4
1.2
iu/ml
59.7
13.7
1.15
22
80
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
112
771
1.90
5.28
4.4
3.7
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
36
162
2.45
5.19
1.6
1.2
titre
408.0
398.7
—
10
30
(3018010) Neutrophils/100 leukocytes in Blood
117
823
1.87
5.10
9.9
4.7
%
58.2
57.4
0.30
111
768
(3002030) Lymphocytes/100 leukocytes in Blood
118
836
1.86
5.00
9.2
4.9
%
27.1
27.7
0.24
112
774
(3022096) Basophils/100 leukocytes in Blood
112
784
1.85
4.90
9.2
4.7
%
0.6
0.7
1.17
106
721
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
61
353
2.00
4.73
1.8
1.5
mg/l
1.6
1.0
0.68
45
265
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
93
645
1.75
3.98
4.2
3.4
ng/l
16.4
32.7
1.75
61
448
(3017143) Hepatitis C virus Ab [Presence] in Serum
35
175
2.18
3.96
1.5
1.6
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
150
1195
1.76
3.86
6.3
3.7
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
72
467
1.80
3.86
2.6
3.2
ng/l
910.7
1064.8
0.16
58
402
(3013650) Neutrophils [#/volume] in Blood by Automated count
133
1026
1.72
3.83
11.1
9.4
e9/l
4.3
4.1
0.33
127
877
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
169
1396
1.84
3.82
4.0
3.8
pmol/l
15.3
14.8
1.02
154
1262
(3013512) EKG study
75
494
1.78
3.81
4.5
3.6
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
38
200
2.08
3.77
3.6
2.3
ug/g
119.3
108.9
0.14
32
160
(3023520) Reticulocytes [#/volume] in Blood
29
137
2.28
3.75
1.4
2.5
e9/l
82.7
68.9
1.03
21
100
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
202
1795
2.18
3.34
19.3
12.6
mg/l
21.9
24.6
0.52
173
1367
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
80
555
1.68
3.30
2.8
2.3
u/l
57.9
56.4
0.08
74
511
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
38
211
1.96
3.26
1.7
1.7
%
1.6
1.5
0.25
33
188
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
115
879
1.63
3.23
5.7
6.9
mmol/l
1.2
1.2
0.14
99
756
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
105
798
1.59
2.94
5.3
5.7
mmol/l
1.2
1.2
0.10
95
723
(3017732) Neutrophils [#/volume] in Blood
23
110
2.21
2.90
1.8
2.5
e9/l
4.3
3.9
0.38
14
90
(40768797) Stomach Pathology biopsy report
41
248
1.80
2.71
1.1
1.2
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
93
704
1.55
2.56
11.9
7.2
inr
1.3
1.2
0.38
24
214
(36660697) Celiac disease serology panel - Serum
25
131
2.02
2.52
1.1
1.2
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
162
1388
1.59
2.52
10.4
7.4
u/l
75.8
78.4
0.50
156
1300
(3024561) Albumin [Mass/volume] in Serum or Plasma
97
745
1.53
2.49
5.3
4.7
g/l
35.8
35.7
0.09
88
691
(3045414) Leukocytes [Presence] in Urine
16
70
2.38
2.47
1.9
1.8
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
8
22
3.73
2.38
1.3
1.4
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
31
180
1.84
2.34
1.9
4.3
u/l
225.8
236.1
0.32
31
173
(3009261) Glucose [Presence] in Urine by Test strip
110
878
1.49
2.30
5.2
3.2
estimate
0.0
0.0
0.00
19
147
(3026389) Candida sp identified in Specimen by Organism specific culture
7
18
3.98
2.27
1.1
1.1
—
—
—
0
0
(3000991) Gas panel - Venous blood
26
144
1.91
2.26
5.8
7.9
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
50
337
1.62
2.23
1.4
1.3
g/l
2.1
2.3
0.47
30
202
(3002032) Base excess in Venous blood by calculation
27
154
1.86
2.16
4.5
3.6
mmol/l
2.1
2.3
0.28
21
120
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
51
354
1.57
2.01
1.6
1.7
pmol/l
268293058.6
442.3
0.49
41
295
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
116
954
1.44
1.99
6.1
6.7
umol/l
9.5
11.4
2.53
110
910
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
23
128
1.89
1.98
2.0
1.4
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
37
238
1.66
1.98
1.6
1.6
—
—
—
0
0
(3022145) Colonoscopy Study observation
32
199
1.71
1.93
1.5
1.3
—
—
—
0
0
(3012544) pH of Venous blood
27
160
1.78
1.92
4.4
3.6
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
53
375
1.54
1.92
6.2
4.5
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
209
1951
1.95
1.92
16.3
11.7
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
187
1695
1.60
1.91
5.3
4.4
mu/l
1.9
2.6
0.52
170
1539
(3021879) Hepatitis B virus core Ab [Presence] in Serum
21
115
1.91
1.90
1.1
1.4
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
7
22
3.25
1.89
1.0
1.0
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
10
40
2.57
1.86
1.3
1.3
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
17
87
2.03
1.85
5.2
8.0
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
6
17
3.60
1.85
1.2
1.1
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
124
1042
1.42
1.84
5.2
4.5
mmol/l
6.8
6.7
0.23
117
966
(3035350) Ketones [Presence] in Urine by Test strip
105
859
1.42
1.80
5.2
3.2
estimate
0.0
0.0
0.00
19
156
(3020564) Creatinine [Moles/volume] in Serum or Plasma
211
1984
1.96
1.76
21.4
14.8
umol/l
77.1
77.2
0.00
211
1984
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
32
205
1.65
1.74
2.8
2.3
umol/l
12.2
8.6
0.26
26
176
(3044640) Blood type and Crossmatch panel - Blood
70
535
1.45
1.74
2.6
2.2
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
54
392
1.50
1.73
2.5
2.2
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
67
508
1.45
1.73
3.9
2.9
—
—
—
0
0
(4062490)
5
13
3.91
1.72
1.4
1.3
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
43
299
1.54
1.68
3.6
2.5
e6/l
1.8
1.2
0.23
34
150
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
26
159
1.72
1.68
1.8
2.1
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
53
386
1.49
1.67
6.5
3.4
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
7
25
2.86
1.66
1.4
1.3
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
7
25
2.86
1.66
1.0
1.2
—
2.3
—
0
7
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
12
56
2.21
1.64
1.2
1.1
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
105
870
1.39
1.63
7.0
4.4
estimate
0.0
0.0
0.00
20
157
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
53
388
1.48
1.63
1.2
1.2
u/ml
4.5
1.3
0.35
13
108
(3008898) HLA-B27 [Presence]
10
43
2.39
1.62
1.2
1.1
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
42
293
1.53
1.62
1.4
1.5
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
195
1804
1.59
1.61
4.2
3.8
mmol/l
1.3
1.3
0.14
179
1650
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
85
682
1.39
1.59
5.6
3.3
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
31
203
1.61
1.56
6.0
7.8
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
142
1242
1.39
1.56
3.8
2.8
u/l
49.7
44.9
0.43
130
1168
(3029937) Albumin [Presence] in Urine by Test strip
61
463
1.43
1.56
5.6
3.4
estimate
0.0
0.0
0.00
18
152
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
7
27
2.64
1.52
1.1
1.1
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
7
27
2.64
1.52
1.0
1.0
—
—
—
0
0
(4010399)
23
140
1.72
1.52
1.2
1.4
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
16
87
1.90
1.50
4.6
3.2
mmol/l
24.9
25.1
0.06
16
87
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
87
707
1.37
1.49
1.8
1.9
pmol/l
89.9
95.9
0.39
42
363
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
15
80
1.94
1.48
3.3
2.6
%
1.3
1.2
0.06
15
80
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
86
700
1.37
1.45
2.6
2.2
nmol/l
78.8
75.6
0.42
77
623
(3004616) Nuclear Ab [Presence] in Serum
5
16
3.17
1.44
1.6
1.4
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
16
89
1.86
1.41
4.1
3.3
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
11
53
2.13
1.41
2.0
3.2
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
51
382
1.43
1.39
6.8
3.5
kg/l
1.0
1.0
—
6
45
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
15
82
1.89
1.39
2.9
2.4
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
9
41
2.24
1.38
1.1
1.1
—
—
—
0
0
(4094501)
9
41
2.24
1.38
1.0
1.1
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
24
152
1.65
1.38
4.0
6.8
mmol/l
1.1
1.4
1.23
24
146
(3025941) Bacteria identified in Stool by Culture
16
90
1.84
1.37
1.6
1.2
—
—
—
0
0
(3022621) pH of Urine by Test strip
19
113
1.74
1.37
2.3
2.6
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
5
17
2.98
1.36
1.2
1.0
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
9
42
2.19
1.35
1.1
1.3
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
97
812
1.34
1.35
11.1
7.7
e9/l
0.0
0.0
0.48
88
650
(1761868) Lipid panel - Serum or Plasma
56
708
0.72
1.30
3.0
2.8
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
29
198
1.53
1.25
1.7
1.6
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
62
490
1.37
1.24
4.0
2.1
u/l
205.1
185.8
0.09
57
466
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
10
49
2.09
1.24
1.3
1.3
—
—
—
0
0
(40758558) Short blood count panel - Blood
57
445
1.38
1.23
8.8
7.2
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
8
38
2.14
1.19
1.1
1.6
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
11
57
1.98
1.19
2.5
1.6
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
75
615
1.33
1.18
3.9
3.4
e6/l
16.7
62.3
2.18
60
429
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
7
30
2.37
1.13
1.3
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
7
30
2.37
1.13
1.3
1.3
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
8
40
2.04
1.13
1.5
2.3
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
39
290
1.42
1.11
1.9
1.8
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
47
362
1.38
1.10
2.4
2.4
e6/l
3.7
7.4
0.87
39
310
(3030467) Casts [#/volume] in Urine by Automated count
62
499
1.33
1.10
3.8
2.7
e6/l
0.2
0.6
0.93
53
355
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
13
74
1.80
1.09
1.2
1.0
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
202
1920
1.49
1.05
5.5
4.7
mmol/l
2.8
2.8
0.09
186
1768
(3041354) Potassium [Moles/volume] in Venous blood
5
22
2.30
1.04
4.0
2.8
mmol/l
4.2
4.0
—
5
22
(3033705) Calcium.ionized [Moles/volume] in Venous blood
5
22
2.30
1.04
4.0
2.8
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
5
22
2.30
1.04
4.0
2.8
mmol/l
109.0
104.9
—
5
22
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
7
34
2.09
1.04
1.3
1.2
—
—
—
0
0
(3019225) pH of Specimen
25
173
1.50
1.03
2.1
4.6
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
31
225
1.44
1.01
2.8
2.4
g/l
2.3
2.3
0.00
31
211
(3014051) Protein [Presence] in Urine by Test strip
7
35
2.03
1.01
2.7
2.0
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
57
459
1.32
1.00
5.8
3.8
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
5
23
2.20
0.98
1.0
1.1
—
—
—
0
0
(3018418) pH of Serum or Plasma
65
536
1.30
0.97
4.4
4.0
ph
7.4
7.4
—
9
96
(3042111) Morphology [Interpretation] in Bone marrow Narrative
6
27
2.25
0.94
1.0
1.5
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
6
28
2.17
0.92
1.5
1.4
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
6
28
2.17
0.92
1.3
1.5
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
7
126
0.54
0.91
1.3
1.5
—
—
—
0
0
(3026782) Osmolality of Urine
44
348
1.33
0.88
3.1
2.5
mosm/kgh2o
539.1
546.0
0.07
37
293
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
6
30
2.03
0.87
1.0
1.1
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
25
180
1.44
0.86
1.9
2.2
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
8
45
1.81
0.85
1.5
1.5
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
6
31
1.96
0.85
4.0
2.8
mmol/l
6.5
8.2
—
6
31
(44816559) Phosphatidylethanol [Mass/volume] in Blood
6
31
1.96
0.85
1.0
1.2
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
65
545
1.27
0.85
3.7
2.9
e6/l
178.9
53.5
0.36
58
404
(3014576) Chloride [Moles/volume] in Serum or Plasma
30
225
1.38
0.83
5.2
6.6
mmol/l
105.5
104.0
1.13
30
217
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
15
97
1.59
0.83
2.1
3.2
mmol/l
0.1
1.3
—
10
81
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
196
1869
1.37
0.83
4.9
4.2
mmol/l
1.5
1.5
0.01
180
1716
(3016650) Hepatitis A virus Ab [Presence] in Serum
6
32
1.90
0.82
1.0
1.0
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
12
185
0.63
0.79
2.0
1.7
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
6
34
1.79
0.77
1.2
3.1
umol/l
34.1
30.6
—
6
27
(3008037) Lactate [Moles/volume] in Venous blood
6
34
1.79
0.77
4.0
2.6
mmol/l
1.3
1.5
—
6
34
(3019060) Gas panel - Arterial blood
17
116
1.50
0.77
3.9
4.0
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
58
486
1.26
0.76
1.9
1.6
mmol/l
1.4
1.4
0.09
49
401
(3013139) Helicobacter pylori Ag [Presence] in Stool
15
100
1.54
0.75
1.4
1.2
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
7
38
1.87
0.74
1.3
1.0
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
7
38
1.87
0.74
1.6
1.5
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
27
204
1.37
0.73
5.4
7.1
mmol/l
0.4
1.2
0.74
19
158
(3001122) Ferritin [Mass/volume] in Serum or Plasma
87
766
1.22
0.73
3.3
2.5
ug/l
152.5
129.4
0.32
80
700
(3041096) Erythrocytes [Presence] in Urine by Automated
59
498
1.25
0.73
3.2
2.7
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
9
57
1.60
0.72
1.3
2.2
ug/l
2012.7
238.3
—
9
52
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
7
40
1.77
0.72
2.9
1.7
g/l
0.0
0.0
—
7
40
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
124
1133
1.21
0.70
3.0
2.9
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
7
41
1.73
0.70
1.1
1.1
—
—
—
0
0
(3044889) 12 lead EKG panel
141
1305
1.21
0.70
3.9
3.6
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
208
2013
1.42
0.69
14.3
9.1
u/l
26.3
25.7
0.23
202
1933
(40761535) Cells panel - Urine sediment
20
145
1.42
0.68
5.3
3.7
—
—
—
0
0
(3022313) Gas panel - Capillary blood
12
78
1.57
0.67
2.0
2.9
—
—
—
0
0
(3000492) Spirometry study
21
155
1.39
0.66
1.6
1.4
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
196
1884
1.30
0.65
5.1
4.2
mmol/l
4.7
4.7
0.16
182
1745
(3034860) Kappa light chains.free [Mass/volume] in Serum
8
50
1.62
0.62
2.8
4.5
mg/l
35.6
41.4
—
8
42
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
8
50
1.62
0.62
2.6
4.5
mg/l
32.9
25.9
—
8
43
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
8
50
1.62
0.62
2.6
4.5
—
3.5
—
0
7
(1761482) Bacteria [#/volume] in Urine by Culture
8
50
1.62
0.62
4.1
4.2
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
181
1727
1.24
0.61
20.8
13.1
%
38.6
40.2
1.23
121
1271
(3042631) Mycobacterium sp identified in Specimen
0
20
0.00
0.60
0.0
2.9
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
21
158
1.36
0.60
4.0
2.9
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
6
36
1.68
0.57
1.8
6.9
—
121.8
—
0
8
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
6
36
1.68
0.57
1.7
1.4
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
6
36
1.68
0.57
1.3
1.2
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
73
646
1.19
0.57
4.5
2.9
—
—
—
0
0
(4035726)
13
179
0.71
0.52
1.3
1.5
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
24
189
1.30
0.52
1.7
1.7
—
—
—
0
0
(4034850)
9
64
1.42
0.52
8.4
9.5
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
24
300
0.78
0.52
1.3
1.4
—
—
—
0
0
(3020891) Body temperature
10
67
1.52
0.50
4.9
4.8
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
11
153
0.70
0.47
1.3
1.3
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
33
275
1.23
0.47
2.6
1.9
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
36
303
1.22
0.47
1.6
1.6
nmol/l
970.1
1230.8
1.42
25
227
(40768804) Tissue Pathology biopsy report
82
744
1.16
0.47
2.0
2.1
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
7
49
1.44
0.46
1.4
1.6
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
7
50
1.41
0.45
1.3
1.3
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
28
230
1.25
0.45
5.3
4.2
%
32.1
32.0
0.01
18
149
(21494755) Public health laboratory ask at order entry panel
16
207
0.76
0.45
1.2
1.4
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
185
1786
1.20
0.44
15.8
11.6
ml/min/173m2
80.7
81.7
0.24
161
1472
(36304419) Bacteria [Presence] in Urine
55
485
1.18
0.44
3.7
2.7
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
14
104
1.37
0.44
1.8
1.6
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
190
1840
1.20
0.43
5.0
4.2
mmol/l
5.8
5.9
1.69
172
1683
(3004588) Protein electrophoresis panel - Serum or Plasma
13
96
1.38
0.42
2.5
2.7
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
5
33
1.53
0.41
1.2
1.8
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
5
33
1.53
0.41
3.6
1.7
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
0
16
0.00
0.41
0.0
1.1
—
276.8
—
0
11
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
0
17
0.00
0.41
0.0
1.5
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
0
17
0.00
0.41
0.0
1.5
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
0
17
0.00
0.41
0.0
1.5
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
0
17
0.00
0.41
0.0
1.5
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
0
17
0.00
0.41
0.0
4.1
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
5
34
1.48
0.40
1.2
1.6
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
6
41
1.48
0.36
1.0
1.2
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
13
100
1.32
0.34
1.4
1.3
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
24
201
1.22
0.34
2.8
1.7
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
179
1736
1.15
0.33
6.4
5.4
mmol/mol
39.1
39.9
0.72
167
1607
(1001926) Buprenorphine [Presence] in Urine by Screen method
6
46
1.31
0.33
3.3
1.5
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
33
287
1.18
0.32
4.1
2.6
e6/l
2.0
2.1
0.04
24
139
(3001019) Free T4 and TSH panel - Serum or Plasma
12
93
1.31
0.30
1.7
1.6
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
46
414
1.14
0.29
1.7
1.5
nmol/l
21.2
21.1
0.02
36
347
(3009508) Creatinine [Moles/volume] in Urine
58
532
1.12
0.28
4.4
3.1
mmol/l
6.6
7.5
1.40
48
450
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
66
613
1.11
0.26
5.7
4.9
ug/l
2.0
3.2
1.20
57
551
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
13
105
1.25
0.25
1.7
1.6
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
26
228
1.16
0.24
5.8
5.2
mmol/l
1.0
1.0
0.36
21
211
(3011288) Drugs identified in Urine by Screen method
5
38
1.32
0.23
26.6
2.1
—
—
—
0
0
(3002256) Pathology report gross observation
21
241
0.86
0.22
1.1
1.3
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
38
345
1.12
0.22
4.8
3.7
ng/l
304.2
272.0
0.04
28
265
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
8
101
0.78
0.21
1.1
1.0
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
5
42
1.19
0.21
1.4
1.2
u/l
4.2
9.3
—
5
35
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.1
—
5.3
—
0
6
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
0
11
0.00
0.21
0.0
2.2
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
1.8
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
1.8
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
0
10
0.00
0.21
0.0
1.8
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
17
145
1.19
0.21
1.1
1.7
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
0
12
0.00
0.21
0.0
1.2
—
2.0
—
0
12
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.5
—
10.5
—
0
13
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
0
13
0.00
0.21
0.0
1.5
—
8.0
—
0
5
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
6
48
1.26
0.20
1.2
1.3
—
—
—
0
0
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
0
14
0.00
0.20
0.0
1.0
—
238.1
—
0
9
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
0
14
0.00
0.20
0.0
1.1
—
34.4
—
0
9
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
18
206
0.86
0.19
2.2
4.6
ug/l
4.3
23.5
0.93
12
185
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
23
204
1.14
0.19
3.0
1.8
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
16
138
1.17
0.18
5.0
3.4
ml/min/173m2
70.1
66.4
—
10
58
(40768443) Skin Pathology biopsy report
7
63
1.11
0.17
1.0
1.2
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
7
63
1.11
0.17
2.7
3.8
mmol/l
3.8
3.9
—
7
57
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
5
67
0.74
0.17
1.0
1.5
—
—
—
0
0
(1002224) Polysomnography panel
8
69
1.17
0.16
1.0
1.1
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
56
530
1.08
0.15
4.1
4.1
mg/mmol
3.9
8.2
1.24
31
343
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
53
501
1.08
0.14
5.6
4.5
%
22.3
21.7
0.11
29
248
(3012516) Albumin [Mass/volume] in Urine
53
501
1.08
0.14
3.5
3.2
mg/l
1657.4
314.3
0.37
25
325
(42529406) Shigella sp [Presence] in Stool by Culture
5
48
1.04
0.09
1.0
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
5
48
1.04
0.09
1.0
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
5
48
1.04
0.09
1.0
1.1
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
19
206
0.92
0.09
1.3
1.5
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
35
369
0.94
0.09
3.4
2.8
ug/l
0.6
0.8
1.52
21
246
(3016879) Cocaine [Presence] in Urine
6
54
1.11
0.09
3.3
1.5
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
6
57
1.05
0.08
3.3
1.5
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
6
57
1.05
0.08
3.3
1.5
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
6
57
1.05
0.08
3.3
1.5
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
5
61
0.82
0.08
2.0
2.1
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
10
88
1.14
0.08
1.5
1.2
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
7
66
1.06
0.08
1.7
3.0
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
6
71
0.84
0.08
1.5
1.5
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
10
89
1.13
0.07
1.6
1.5
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
53
517
1.03
0.04
1.4
1.4
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
15
141
1.07
0.03
3.7
3.2
—
—
—
0
0
(3003338) MCHC [Mass/volume]
161
1600
1.02
0.02
26.7
16.4
g/l
332.0
332.7
0.44
161
1595
(3015377) Calcium [Moles/volume] in Serum or Plasma
61
606
1.01
0.00
1.9
3.9
mmol/l
2.3
2.4
0.88
49
531
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
6
0.00
0.00
0.0
1.3
—
8.6
—
0
6
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
7
0.00
0.00
0.0
3.4
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
0
6
0.00
0.00
0.0
4.2
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3016244) Insulin [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
5.8
—
10.6
—
0
6
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3034426) Prothrombin time (PT)
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
7
0.00
0.00
0.0
3.4
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
0
7
0.00
0.00
0.0
6.3
—
45.3
—
0
7
(3017569) Oxygen content in Arterial blood
0
7
0.00
0.00
0.0
10.4
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
6
62
0.97
0.00
1.3
1.9
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014891) Appearance of Pleural fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
2.1
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(44806420)
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
6
65
0.92
0.00
1.2
1.7
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(4198724)
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
5
56
0.89
0.00
2.6
1.9
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
5
57
0.87
0.00
1.6
1.5
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
0
8
0.00
0.00
0.0
9.2
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint M13_FINGERDEFORM and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| M13_FINGERDEFORM | 1.24 [0.96, 1.6] | 0.096 |
| Birth year | 0.999 [0.99, 1.01] | 0.752 |
During the follow-up period (1.1.1998 — 31.12.2019), 81 out of 690 females with M13_FINGERDEFORM died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| M13_FINGERDEFORM | 1.117 [0.87, 1.43] | 0.381 |
| Birth year | 0.991 [0.98, 1.0] | 0.189 |
During the follow-up period (1.1.1998 — 31.12.2019), 81 out of 494 males with M13_FINGERDEFORM died.
Mortality risk
Mortality risk for people of age
years, who have M13_FINGERDEFORM.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.155% | 0.254% |
| 5 | 0.81% | 1.674% |
| 10 | 2.038% | 3.989% |
| 15 | 3.924% | 7.081% |
| 20 | 6.915% | 11.933% |
Relationships between endpoints
↥Index endpoint: M13_FINGERDEFORM – Deformity of finger(s)
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data